Steven Marotta
Stock Analyst at CL King
(0.54)
# 4,108
Out of 5,182 analysts
15
Total ratings
37.5%
Success rate
-15.08%
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $31.68 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $37.83 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $4.46 | +527.80% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $7.97 | +414.43% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $13.42 | +116.10% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $103.39 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $35.40 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $31.68
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $37.83
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $4.46
Upside: +527.80%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $7.97
Upside: +414.43%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $13.42
Upside: +116.10%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $103.39
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $35.40
Upside: -